The Food and Drug Administration (FDA) has approved Andembry ® (garadacimab-gxii) for prophylactic use to prevent attacks of hereditary angioedema (HAE) in adult and pediatric patients aged 12 ...

Efficacy, safety, and immunogenicity results were also found to be comparable. Yuflyma is supplied as a prefilled syringe in 20mg/0.2mL, 40mg/0.4mL and 80mg/0.8mL dosage strengths and as an ...